Seratrodast|cas 112665-43-7|DC Chemicals

Seratrodast|cas 112665-43-7|DC Chemicals

Seratrodast(AA 2414) is a potent and selective thromboxane A2 receptor (TP) antagonist.

Target: Thromboxane A2 Receptor

Seratrodast, also known as AA-2414, is a potent and selective antagonist of the TXA2R (thromboxane A2 receptor).

Product Name: Seratrodast|Cat No: DC9566|Cas: 112665-43-7|Molecule Formular: C22H26O4|Molecule Weight: 354.4395|Other names: Seratrodast

Seratrodast(AA 2414) is a potent and selective thromboxane A2 receptor (TP) antagonist.
Seratrodast, also known as AA-2414, is a potent and selective antagonist of the TXA2R (thromboxane A2 receptor). AA-2414 reduced the induction of pulmonary inflation caused by LTD4 aerosol inhalation. AA-2414 competitively inhibited the contractile response to U-46619 in guinea pig tracheal and parenchymal strips and dog saphenous vein strips with pA2 values of 7.69, 8.29 and 6.79, respectively. AA-2414, a quinone derivative, is a novel, potent and orally active antagonist of a variety of spasmogenic prostanoids. AA-2414 inhibited peroxide-induced vasoconstriction in the human placenta, as well as peroxide- induced increases in the placental secretion rates of lipid peroxides and thromboxane, but only partially inhibited peroxide-induced increases in the placental secretion rate of prostacyclin.

For research only, not for human use!